Get started
Author

Suzy Scholl

Observed names: S M Scholl, S Scholl, S. M. SCHOLL, S. M. Scholl, S. SCHOLL, S. Scholl, S.M Scholl, S.M. Scholl, SM Scholl, SUSY SCHOLL, Susy M Scholl, Susy M. E. Scholl, Susy M. Scholl, Susy Scholl, Suzy M Scholl, Suzy M. E. Scholl, Suzy M. Scholl, Suzy Marie Elisabeth Scholl
Observed institutions: Goethe University Frankfurt, Centre National de la Recherche Scientifique, National Institutes of Health, Kaiser Permanente, Inserm, University of California, Los Angeles, University of California, San Francisco, Genentech, Université Paris Sciences et Lettres, Université Paris-Saclay, Mount Vernon Hospital, Institut Gustave Roussy, Ludwig Cancer Research, National Cancer Institute, Addenbrooke's Hospital, Biologie cellulaire et Cancer, Pathologisches Institut, Université Pierre-et-Marie-Curie, Institut Curie, Ludwig-Maximilians-Universität München
ORCID: 0000-0003-0277-6219
Observed ORCID: 0000-0003-0277-6219
OpenAlex ID: A5085752463
Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease
1999 · Melody A. Cobleigh, Charles L. Vogel, et al. · Journal of Clinical Oncology · 2,772
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
2017 · Bernard Asselain, William Barlow, et al. · The Lancet Oncology · 1,188
PDF
Therapeutic vaccines for cancer: an overview of clinical trials
2014 · Ignacio Melero, Gustav Gaudernack, et al. · Nature Reviews Clinical Oncology · 794
Recommendations From an International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer: An Update
2006 · Manfred Kaufmann, Gabriel N. Hortobagyi, et al. · Journal of Clinical Oncology · 734
PDF
Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6
1994 · S.M. Scholl, A. Fourquet, et al. · European Journal of Cancer · 424
Comparison of the 5-Hydroxytryptamine 3 (Serotonin) Antagonist Ondansetron (Gr 38032F) with High-Dose Metoclopramide in the Control of Cisplatin-Induced Emesis
1990 · Michel Marty, Pierre Pouillart, et al. · New England Journal of Medicine · 402
Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer.
2001 · F Le Naour, D E Misek, et al. · PubMed · 307
Anti-Colony-Stimulating Factor-1 Antibody Staining in Primary Breast Adenocarcinomas Correlates With Marked Inflammatory Cell Infiltrates and Prognosis
1994 · S. M. Scholl, C. Pallud, et al. · JNCI Journal of the National Cancer Institute · 233
Circulating HPV DNA as a Marker for Early Detection of Relapse in Patients with Cervical Cancer
2021 · Emmanuelle Jeannot, Aurélien Latouche, et al. · Clinical Cancer Research · 179
PDF
Targeting HER2 in other tumor types
2001 · S. Scholl, P. Beuzeboc, et al. · Annals of Oncology · 166
Breast tumour response to primary chemotherapy predicts local and distant control as well as survival
1995 · S.M. Scholl, J.Y. Pierga, et al. · European Journal of Cancer · 151
Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease
2023 · Melody A. Cobleigh, Charles L. Vogel, et al. · Journal of Clinical Oncology · 146
Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy
2011 · Jean-Luc Brun, Véronique Dalstein, et al. · American Journal of Obstetrics and Gynecology · 144
Recombinant Vaccinia Virus Encoding Human MUC1 and IL2 as Immunotherapy in Patients With Breast Cancer
2000 · Susy M. Scholl, Jean-Marc Balloul, et al. · Journal of Immunotherapy · 130
Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer
2000 · J-Y Pierga, E Mouret, et al. · British Journal of Cancer · 126
PDF
M‐CSF (monocyte colony stimulating factor) and M‐CSF receptor expression by breast tumour cells: M‐CSF mediated recruitment of tumour infiltrating monocytes?
1992 · Ruoping Tang, Mario Ojeda, et al. · Journal of Cellular Biochemistry · 103
Neoadjuvant chemotherapy in operable breast cancer
1991 · S.M. Scholl, B. Asselain, et al. · European Journal of Cancer and Clinical Oncology · 102
Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site
2020 · Maud Kamal, Sonia Lameiras, et al. · British Journal of Cancer · 94
PDF
Circulating macrophage colony stimulating factor as a marker of tumour progression.
2002 · Raymond S McDermott, Laurent Deneux, et al. · PubMed · 86
Prognostic factors in inflammatory breast cancer and therapeutic implications
1994 · T. Palangie, V. Mosseri, et al. · European Journal of Cancer · 81
Simultaneous bilateral breast carcinomas: A retrospective review of 149 cases
1994 · Anne de la Rochefordiere, Bernard Asselain, et al. · International Journal of Radiation Oncology*Biology*Physics · 75
Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers: A role for hematopoietic growth factor release by tumor cells?
1990 · Ruoping Tang, Barry Kacinski, et al. · Journal of Cellular Biochemistry · 73
Circulating levels of colony-stimulating factor 1 as a prognostic indicator in 82 patients with epithelial ovarian cancer
1994 · SM Scholl, CH Bascou, et al. · British Journal of Cancer · 70
PDF
Resection of pulmonary metastases in osteosarcoma. A retrospective analysis of 44 patients
1989 · Laura Belli, Susy Scholl, et al. · Cancer · 65
Prevalence of human papillomavirus type 16 DNA in cervical carcinoma samples in East Anglia
1985 · S. M. Scholl, E. M. Kingsley Pillers, et al. · International Journal of Cancer · 65
Works count: 146
Citation count: 9,758
H-index: 35
I10-index: 60
Year
Topic
Type